Company Name, Ticker, Industry, else..

Aei Income and Growth Fund Xxi Limited Partnership (NONE)

Other Ticker:

Sector • Technology Industry • Electronic Instruments & Controls

Industry • Electronic Instruments & Controls

Sector • Technology

The Top-line plunged at NONE during the fourth quarter of 2022

NONE announced fourth quarter of 2022 operating surplus of $0.994179 millions

Published 2023-04-02T03:08:12+00:00
Goran Soko / CSIMarket.com Contributer

For the fiscal fourth quarter of 2022 NONE profits turned positive of $0.01 per share compare to $-0.14 a year before and EPS dropped by -99.63 % from $1.64 per share from the preceding quarter.
Interior_pd

Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the comparable quarter a year before and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.

Aei Income And Growth Fund Xxi Limited Partnership booked earnings of $2.278 millions in the fiscal fourth quarter of 2022 an improvement versus a net deficit of $-0.051 millions in the comparable quarter a year ago. Aei Income And Growth Fund Xxi Limited Partnership also emphasized it's improving profit margins, where net margin rose to 1178.13% in fiscal fourth quarter of 2022, and operating margin edged up to 514.22%.
Looking further into Aei Income And Growth Fund Xxi Limited Partnerships' reports for the financial period 2022, NONE disclosed Revenues of $0.89 millions and earnings of $1.53 millions.

Electronic Instruments & Controls company noticed also, that Eps surged by 522.66 % to $87.92 per share from $14.12 in the preceding financial period , contributes by -99.97 % from $3.30 billions a year before.

Aei Income And Growth Fund Xxi Limited Partnership is expected to report next financial results on April 04, 2023.

Aei Income And Growth Fund Xxi Limited Partnership Customers

Aei Income And Growth Fund Xxi Limited Partnership Suppliers

Recently Reported Results

Quaint Oak Bancorp Inc

A humbling fiscal period by QNTO amid the financial fourth quarter of 2022

For the financial interval ending December 31 2022 QNTO net profit per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year prior and profit plummeted by -55.19 % from $1.22 per share from the previous reporting period.

Revenues depreciated by -6.343 % to $8.80 millions from $9.40 millions in the comparable reporting period a year prior and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc Suppliers

Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Auto Sales

Ford surpasses GM in December

Monthly, quarterly and annual vehicle sales

Vehicle production and Market share

NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Invesco Db G10 Currency Harvest Fund

In the most recent fiscal period DBV reached 0 at $0.00 per share, opposite of $0.00 per share a year ago quarter, In the preceding quarter The company realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile

Invesco Db G10 Currency Harvest Fund Income Statement, Balance sheets, Cash Flow Statement

Bay_Club_By_WPPilot_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Galaxy Gaming Inc

Contraction in profitability in spite of Increase in business at in the October to December 31 2022 span

GLXZ disclosed declining eps on increasing revenue in the October to December 31 2022 span, where Revenue increased by 4.764 % to $5.94 millions compared to $5.67 millions on a year-over-year basis, while reached zero gain to $0.00 per share, income per share was $0.02 in the corresponding interval a year before.

Galaxy Gaming Inc Suppliers

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Calithera Biosciences Inc

The company added some good story for the shareholders, presenting a genuine improvement in fourth quarter of 2022 financial report with operating deficit of $-7.346 millions

The investors have not expected any modifications at the top-line throughout the the October to December 31 2022 reporting season at the company. However, shareholders observe CALAs' operating deficit which has been at $-7.346 millions, in the same period.

Calithera Biosciences Inc Customers

Calithera Biosciences Inc Income Statement, Balance sheets, Cash Flow Statement

Shipping_Containers_at_the_terminal_at_Port_Elizabeth,_New_Jersey2_pd

International Trade

The Nations Trade deficit widens on falling exports according to the December 2022 data

The U.S. trade gap widened in December 2022, on the decline in exports and growth in imports.

Factory Orders

Factory orders rebounded in December

U.S. Factory orders grew again after dipping in the last month, but Shipments of durable goods fell by -0.73 % to $543 billions.

Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Retail Inventories

U.S. retail inventories rise in September

The retail inventories growth rate accelerated compare to the slow down in previous month, due to growing inventories at the car dealars.

Oil_platform_By_Divulgacao_Petrobras__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Vantage Drilling International

Fading Diminishing Returns at VDI all along the financial fourth quarter of 2022

Respectable Revenue elevation in the fourth quarter of 2022 financial report, by 52.984 % to $76.19 millions fueled to cut losses to $-1.33 per share, from $-1.79 in comparable the financial reporting period a year ago.

Vantage Drilling International Competitors, Market Share

Vantage Drilling International elevation Rates, Profitability, PE

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Surrozen Inc

The Biotechnology & Pharmaceuticals company announced Revenue of $12.5 millions, in the October to December 31 2022 three months

SRZN revealed $12.5 millions, in Revenue in the fiscal period closing December 31 2022.

Surrozen Inc Customers

Surrozen Inc rise Rates, Profitability, PE

Justine_Ezarik_By_Brian_Solis__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common

Ast Spacemobile Inc

Considering the fiscal span closing Dec 31 2022 Ast Spacemobile Inc reached balanced books at $0.00 per share, relative to the recent numbers of $0.32 per share a year prior reporting period, In the preceding reporting period the Communications Services company realized $-0.18 per share.

Ast Spacemobile Inc Customers

Ast Spacemobile Inc Suppliers

pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Talaris Therapeutics Inc

The emerging corporation from the Biotechnology & Pharmaceuticals sector the TALS reported the financial time-frame ending fourth quarter of 2022, numbers

The Biotechnology & Pharmaceuticals industry advisors continue to analyze the fourth quarter of 2022 performance. Now those advisors monitor operating deficit of $-19.825 millions, from the Talaris Therapeutics Inc , as it has not specified any revenue so far, for the respective October to December 31 2022 financial reporting period.

Talaris Therapeutics Inc Customers

Talaris Therapeutics Inc growth Rates, Profitability, PE

Inhibikase Therapeutics Inc

Astonishing 3169.856%, surge in Revenues , by the company during the fourth quarter of 2022 earnings season

For the October to December 31 2022 period company decreased a loss per share of $-0.17 per share compare to $-0.20 a year ago and earnings per share improved from $-0.18 per share from the prior reporting season.

Revenues grew sharply to $0.06 millions from $0.00 millions in the similar reporting season a year ago and sequentially Revenue doubled by 771.842 % from $0.01 millions.

Inhibikase Therapeutics Inc Customers

Inhibikase Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Scynexis Inc

The company reported unusual results, in the most recent fiscal period

For the fiscal fourth quarter of 2022 Scynexis Inc decreased a loss per share of $-0.22 per share compare to $-1.08 a year ago and EPS improved from $-0.62 per share from the prior quarter.

Revenues grew sharply by 155.276 % to $1.52 millions from $0.60 millions in the same quarter a year ago and sequentially Revenue decreased by -2.119 % from $1.56 millions.

Scynexis Inc Suppliers

Other NONE's Earnings Reports

Aei Income And Growth Fund Xxi Limited Partnership reported third quarter 2022 earnings

Aei Income And Growth Fund Xxi Limited Partnership reported second quarter 2022 earnings

Aei Income And Growth Fund Xxi Limited Partnership reported first quarter 2022 earnings


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar XBIO's Profile Stock Price XBIO's Financials Business Description Fundamentals Charts & Quotes XBIO's News Suppliers XBIO's Competitors Customers & Markets Economic Indicators XBIO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071